About R. Scott Blackley
R. Scott Blackley is a director at Hexamer Therapeutics.
R. Scott Blackley first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name R. Scott Blackley in the role, so the role may have started earlier or lasted longer.
Hexamer Therapeutics, Inc
Director
2024 – 2026 · Pullman, WA
Develops vaccine technologies for human cancer and infectious diseases and for animal health companies.
Key Colleagues at Startups
The people R. Scott Blackley works with at each company, as listed on that company's latest Form D.
Hexamer Therapeutics, Inc · Form D, Sep 15, 2026
Robert Bogden
Chief Executive Officer (CEO) and director
BC
Brad Call
Director
Keith Miller
Chief Technology Officer (CTO) and director
CC
Colin Collins
Chief Scientific Officer and Co-Founder, director
SC
Stephen Crawford
Director